Clinical Study

Physical Feature Encoding and Word Recognition Abilities Are Altered in Children with Intractable Epilepsy: Preliminary Neuromagnetic Evidence

Table 1

Characteristics of patients.

Nr.DemographicsDiagnosis SideEpilepsy onset, years Epilepsy duration years Pathology Average spike frequencyb Antiepileptic drugscNeuropsychological examSeizure outcome F/U duration (mo)
Age, ySexDHEpilepsy focusaVCIPRIWMIPSIFSIQWJ L-WWJ PcompEngel’s class

113FRTemporalL67FCD 2A17Lamotrigine, topiramate, clonazepam799494103887976Class 124

214FRFrontal, temporalL68FCD 1B33Levetiracetam, ethosuximide, methosuximide67825268606575Class 128

315MRFrontalL132FCD 1A38Gabapentin, divalproex sodium93102807084113104Class 126

412MROccipital, temporalL77old ische-mic change46Levetiracetam, oxcarbazepine, zonisamide876765626510191Class 136

512MRFrontalR84FCD 2A0Topiramate, lamotrigine71945078628767Class 119

611FRTemporal, parietalL65FCD 2B100Levetiracetam, lamotrigine, clonazepamNT988888859599Class 115

714MRFrontal, parietal, temporalR131NA14Oxcarbazepine, gabapentinNTNTNTNTNT8978No surgery yetNA

810MRParietalL82FCD 1B0Levetiracetam, divalproex sodium1151021029110510797Class 147

917MRTemporal, frontalL58FCD 1B5Levetiracetam73737175689392Class 119

1016FRFrontal, temporalL79NA0Lamotrigine, levetiracetamNTNTNTNTNT10596No surgery yetNA

M
± SD
13.4 ± 2.27.9 ± 2.85.3 ± 2.925.3 ± 31.287.4
± 16.9
92.7 ± 12.476.8 ± 19.278.5 ± 14.280
± 16.03
93.4 ± 14.387.5
± 12.5
26.8 ± 10.4

Min105106767506260656715

Max1713910011510310210310511310447

F: female; M: male; R: right; L: left; NT: not tested; NA: not applicable; DH: Dominant Hand; FCD: focal cortical dysplasia; VCI: Verbal Comprehension Index; PRI: Perceptual Reasoning Index; PSI: Processing Speed Index; WMI: Working Memory Index; FSIQ: Full Scale IQ; WJ L-W: Letter-Word Identification; and WJ Pcomp: Passage Comprehension.
aA major epilepsy focus is marked with a star .
bNumber of spikes in 40 min of MEG.
cGiven the night before study (at least 12 h).